Belgium· BE-AMP-SAM525217-00
Elebrato Ellipta 92 µg/dose - 22 µg/dose
A vilanterol, umeclidinium bromid und fluticason furoat product containing umeclidinium bromide, registered in Belgium by GlaxoSmithKline Trading Services. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vilanterol, umeclidinium bromid und fluticason furoat is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL08 (vilanterol, umeclidinium bromid und fluticason furoat), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Vilanterol, umeclidinium bromid und fluticason furoat · ATC R03AL08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Umeclidinium Bromide
- Manufacturer
- GlaxoSmithKline Trading Services
- Country
- Belgium (BE)
- ATC code
- R03AL08
- ATC class
- Vilanterol, Umeclidinium bromid und Fluticason furoat
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vilanterol, umeclidinium bromid und fluticason furoat in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIncruse Ellipta 55micrograms/dose dry powder inhalerCST Pharma Ltd
- CzechiaINCRUSE ELLIPTAGlaxoSmithKline Trading Services Limited, Dublin
- SpainINCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSISGlaxosmithkline Trading Services Limited
- FinlandIncruse ElliptaGlaxoSmithKline Trading Services Limited
- NetherlandsIncruse Ellipta 55 microgram inhalatiepoeder, voorverdeeldGlaxoSmithKline Trading Services Limited
- United StatesIncruse ElliptaGlaxoSmithKline LLC
- SwitzerlandIncruse Ellipta
- IrelandIncruse Ellipta 55 micrograms inhalation powder, pre-dispensedGlaxoSmithKline Trading Services Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Incruse Ellipta, Rolufta Ellipta
- Liechtenstein · Incruse Ellipta, Rolufta Ellipta
- Norway · Incruse Ellipta, Rolufta Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4149407f-dfd8-4456-a302-28698a47ad87 GET /v1/drugs/4149407f-dfd8-4456-a302-28698a47ad87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalation powder, pre-dispensed",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Elebrato Ellipta 92 µg/dose - 22 µg/dose",
"name_fr": "Elebrato Ellipta 92 µg/dose - 22 µg/dose",
"name_nl": "Elebrato Ellipta 92 µg/dose - 22 µg/dose",
"amp_code": "SAM525217-00",
"strengths": [
"65.0000",
"55.0000",
"22.0000",
"92.0000",
"25.0000"
],
"pack_count": 3,
"substances": [
"Umeclidinium Bromide",
"Umeclidinium",
"Vilanterol Trifenatate",
"Vilanterol",
"Fluticasone Furoate",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vilanterol, Umeclidinium Bromide and Fluticasone Furoate",
"authorisation_numbers": [
"EU/1/17/1237/003",
"EU/1/17/1237/002",
"EU/1/17/1237/001"
]
}See everything about vilanterol, umeclidinium bromid und fluticason furoat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.